Lin Xia
Yuanzhi Chen
Tianying Zhang
Yiwen Wang
Bing Zhou
Min You
Quan Yuan
Chi-Meng Tzeng
Zhiqiang An
Wenxin Luo
Ningshao Xia
1 State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, School of Life Science, Xiamen University, Xiamen 361105, China;
2 Key Laboratory for Cancer T-Cell Theranostics and Clinical Translation(CTCTCT), Translational Medicine Research Center, School of Pharmaceutical Science, Xiamen University, Xiamen 361105, China;
3 Texas Therapeutics Institute, The Brown Foundation Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX 77030, USA
Funds: This work was financially supported by China Postdoctoral Science Foundation (No. 2016M600504). This work was also supported by Natural Science Foundation of Fujian Province (No. 2017J01066) and National Natural Science Foundation of China (Grant Nos. 31600748 and 81672111).
Abstract
PDF全文下载地址:
http://www.protein-cell.org/article/exportPdf?id=6928d389-916d-4b88-906d-77adec1de42f&language=en